Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Swedish BioFINDER 2 Study

NCT03174938 is registered in ClinicalTrials.gov with Skane University Hospital as lead sponsor.

NCT NCT03174938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03174938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Swedish BioFINDER 2 Study
Lead sponsor
Skane University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 15, 2017
Completion date
December 31, 2036
Enrollment
2,950 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

als (amyotrophic lateral sclerosis), alzheimer disease, corticobasal degeneration, dementia, frontotemporal degeneration, lewy body disease, mild cognitive impairment, multiple system atrophy, parkinson disease, parkinson-dementia syndrome, progressive nonfluent aphasia, progressive supranuclear palsy, semantic dementia